Navigation Links
Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
Date:3/14/2013

LONDON, March 14, 2013 /PRNewswire/ --

The expiration of patents on several blockbuster drugs has been one of the major trends in the biotechnology sector in the last few years. As major pharmaceutical companies face increasing generic competition following patent expirations, they are likely to see a negative impact on their top-line. Big pharmaceutical companies have been looking to boost their product pipeline to offset the impact of the patent cliff. Another trend that could emerge as a result of this development is acquisitions. Big pharma companies may look to acquire smaller biotechnology companies that are developing potential blockbuster drugs. Companies such as Sequenom Inc. (NASDAQ: SQNM), Peregrine Pharmaceuticals (NASDAQ: PPHM), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX), and Inovio Pharmaceuticals Inc. (NYSEAMEX: INO) could be among the ideal takeover targets for major pharmaceutical companies. On Wednesday, biotech stocks ended on a mixed note even as the Dow Jones posted its ninth successive higher finish. StockCall has posted free technical research reports on SQNM, PPHM, ONXX, and INO and these can be accessed by signing up at

http://www.stockcall.com/analysis

Sequenom Inc. shares posted modest gains on Wednesday, closing 0.45% higher at $4.48. The stock touched an intra-day high of $4.51, and has gained nearly 4% this week. Despite the recent gains, the biotech company's shares have fallen nearly 5% this year, even as the broad market has posted significant gains for the year. The company's shares have been struggling to break through $4.60 resistance level. The stock has just moved above its 50-day moving average, though, which is a bullish signal. The stock's MACD has also crossed above the zero-line, which further confirms the positive trend.  Download the free report on SQNM upon registration at

http://www.StockCall.com/SQNM031413.pdf  

Peregrine Pharmaceuticals shares saw a sharp decline in Wednesday's session as investors digested the company's quarterly results. The stock closed 6.33% lower at $1.48 after touching an intra-day low of $1.43. The company's shares are down more than 10% for the week. Despite the recent losses, the stock has outperformed the broad market this year. Year-to-date, Peregrine's shares have gained over 12% as compared to a jump of 9% for the S&P 500. The MACD chart for PPHM is giving bearish signal at the moment. The stock is also trading below its 50-day moving average. PPHM technical report can be accessed for free by signing up at

http://www.StockCall.com/PPHM031413.pdf  

Although Onyx Pharmaceuticals Inc. shares edged lower in trading yesterday, losses were limited. The stock ended the day 0.61% lower at $87.29 after falling to an intra-day low of $88.55. Onyx's shares are up nearly 2% for the week, despite Wednesday's pullback. The stock has had an excellent run so far this year, gaining more than 15%. The company's shares have seen a series of highs over the last few trading sessions, which is a bullish signal. The upbeat trend is confirmed by recent volume activity. The free report on ONXX can be downloaded by signing up now at

http://www.StockCall.com/ONXX031413.pdf  

Shares of Inovio Pharmaceuticals Inc. gained in the previous trading session, closing 0.43% higher at $0.540 on above average volume of 2.99 million yesterday. Inovio's shares had fallen sharply last week; however, the stock has bottomed out at around $0.525. Free report on INO can be accessed by registering at

http://www.StockCall.com/INO031413.pdf  

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com  


'/>"/>
SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
2. Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
3. More than Morning Sickness: Kate Middletons Pregnancy Announcement Draws Attention to Rare Pregnancy Condition Known as Hyperemesis Gravidarum (HG)
4. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
8. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
9. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
10. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
11. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016 Potrero ... system, is pleased to announce the appointment of George ... San Antonio, TX , WellMed is ... servicing over 200,000 patients and HMO members in ... founding WellMed in 1990 out of his own internal medicine ...
(Date:2/11/2016)... 2016  AfterPill.com is reporting that this week,s Centers ... all women who are at risk of unintended pregnancy ... and raises the risks of unprotected sex in particular.  ... According to the Guttmacher Institute, there are 43 million ... age, who have sex without the intention of becoming ...
(Date:2/11/2016)... 11, 2016  Proliant Biologicals is proud to announce ... (BSA) manufacturing facility.  The facility is located on the ... in Feilding. Boone , Iowa.  ... duplicate the systems in the U.S. facility, with critical ... U.S. installations.  --> Boone ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western University ... Match Program Tuesday, February 9, taking one of the final steps in their ... education positions across the country. Of the 103 student-doctors who comprise the College ...
(Date:2/11/2016)... Nashville, TN (PRWEB) , ... February 11, 2016 , ... ... commercial cleaning business to a new market, and it’s the buildings of Nashville that ... much that when I needed to relocate to Nashville, there was no question that ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a ... is pleased to announce the promotions of Allison Kelly to executive vice president ... to executive vice president of North American capital sales, and Wendy Oseas to ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... ?" motivational speaker, trainer and author Ray Clarke poses a question as a ... fulfillment . In his book, "Being in the Being" (published by Partridge Singapore), ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... updated its hallmark resource, Infusion Therapy Standards of Practice, to include vascular visualization ... illumination with an estimated 85% share of the market, facilitates adherence to this ...
Breaking Medicine News(10 mins):